Social Media Use Among Young Adults With Connective Tissue Disorders: Cross-Sectional Pilot Study

Abstract

Background Young people with genetic conditions often face challenges coping with their health condition. It can be difficult for them to meet someone with a similar condition, which is important for reinforcement of chronic illness management recommendations. Social media is used by 97% of young people in the United States and may provide those with these disorders a space for emotional expression and support. However, there is a scarcity of literature related to the use of social media among adolescents with genetic conditions as an indicator of their perception regarding their own condition. Objective The purpose of this pilot study was to obtain preliminary data to assess and understand social media use by young people with connective tissue disorders and determine whether they use social media to connect with patients with similar conditions or whether they would be interested in doing so. Methods We undertook a pilot study of selected connective tissue disorders occurring in young people between the ages of 11 and 25 years, including Marfan syndrome; Ehlers-Danlos syndrome subtypes classical, classical-like, cardiac-valvular, and vascular; Beals congenital contractual arachnodactyly; and Alport hereditary nephritis. The study took place within one pediatric clinical system. Patients were identified through electronic medical record search and International Classification of Diseases, Ninth Revision, coding at a Midwest university–based clinical system. Study subjects completed a short survey describing their experiences with their connective tissue disorders, their means of self-expression, their existing network of persons to communicate with, and their use of social media. Data analysis included nominal and bivariate regressions to compare social media use in relation to age. Results Our 31 participants (42% response rate) were 55% female (17/31) and their average age was 18 years (SD 5). All participants used social media and there were no statistically significant differences between social media use and age. The majority of participants (25/30, 83%) reported that they never used social media to discuss their condition (P=.09), and only 17% (5/30) knew someone online with a similar condition (P=.50). Most participants (19/30, 63%) said they would communicate with someone with a similar disorder (P=.64). Conclusions We found that young individuals with connective tissue disorders use at least one type of social media. A majority did not use social media to discuss their condition or know someone online with a similar condition. However, many persons were interested in finding others similarly affected. Social media could serve as a platform for young people with connective tissue disorders to connect. Peer support is important in disease management and adolescent development. Future studies should aim at understanding social media use among young people with connective tissue disorders and helping them connect with other people who have similar conditions.

Contrasting Social Media Use Between Young Adults With Inflammatory Bowel Disease and Type 1 Diabetes: Cross-sectional Study

“…One Italian study that studied patients with 4 conditions, including IBD and T1D, found that 98% expressed a need to share their medical condition on social media [ 14 ]. However, another study of patients with connective tissue disorders noted only 17% revealed their condition on social media [ 15 ]. These studies can be used to put the disclosure rate of young adults with IBD and T1D in context.…”

Social Media and Adolescent Mental Health: Sounding the Alarm

“…Additionally, social media provides easy access to a forum where individuals can turn for social support. Online social networking allows for communities, such as the LGBTQ (lesbian, gay, bisexual, transgender, and queer or questioning) community or communities of children with chronic health conditions, to meet and interact with each other (Kelleher et al, 2020; Sherrell & Johnson, 2021).…”

Connective tissue disease in the practice of a cosmetologist and dermatologist. Features of diagnosis and management of patients

“…За рубежом термином «дисплазия соединительной ткани» называют гетерогенную группу наследственных заболеваний (таких как синдром Марфана, синдром Элерса -Данлоса) [13]. Другие авторы термином "undifferentiated (mixed) connective tissue dysplasia" (недифференцированная дисплазия соединительной ткани) называют группу аутоиммунных заболеваний, включая системную красную волчанку, системный склероз, идиопатические воспалительные миопатии, синдром Шегрена и ревматоидный артрит, в связи с чем может быть некоторая путаница при переводе (в российской классификации термином «недифференцированная дисплазия соединительной ткани» называют несиндромные мультифакториальные дисплазии соединительной ткани) [14].…”